Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Cyprus Won’t Hold Back the Dow: JPMorgan Chase & Co. (JPM), Bank of America Corp (BAC), Incyte Corporation (INCY)

With the stock market near record highs, investors are on edge, and the slightest hint of trouble can cause near-panic. Given the news over the weekend that not only will the European island nation of Cyprus need a bailout, but it will also come at the expense of bank depositors, visions of Great Depression-era bank runs and rhetoric about the confiscation of funds led to massive sell-offs in overseas stock markets. Yet as Fool contributor Morgan Housel noted earlier this morning, Cyprus’ bailout doesn’t deserve the huge hype that it’s getting. At least in the U.S., investors seem to have gotten that message, as the Dow Jones Industrials have recovered from initial losses of more than 100 points to trade down just 31 points as of 10:55 a.m. EDT. Broader markets are down roughly half a percent.

JPMorgan Chase & Co. (JPM)

Within the Dow, banking stocks took the most substantial hit, with Bank of America Corp (NYSE:BAC) down more than 1% and JPMorgan Chase & Co (NYSE:JPM) falling 1.2%. The biggest threat from the Cypriot bailout is that bank customers in other countries will leap to the almost certainly false conclusion that their own deposits are at risk. With FDIC insurance, U.S. depositors are protected, but with ordinary Americans already predisposed against the banking industry, anything that leads more bank customers to withdraw deposits will only put an additional strain on the financial system.

Elsewhere, Incyte Corporation (NASDAQ:INCY) declined 7.2% after the company reported that a patient taking its myelofibrosis drug ruxolitinib contracted a disease called progressive multifocal leukoencephalopathy. Although this is the first case of PML associated with the drug, Incyte will get an independent assessment of the findings and could have to take additional steps in order to ensure the safety of the drug.

Finally, J.C. Penney Company, Inc. (NYSE:JCP) soared more than 8% as two pieces of news helped boost the struggling retailer. One analyst said the company’s Joe Fresh concept has had a successful launch among customers, while a research group examining the value of the retailer’s real estate estimated that Penney could earn $1.2 billion in rental income by subletting store locations. Any move to unlock income will help the company, as it has been burning cash at an alarming rate during its restructuring.

The article Why Cyprus Won’t Hold Back the Dow originally appeared on and is written by Dan Caplinger.

Fool contributor Dan Caplinger owns warrants on Bank of America and JPMorgan Chase. The Motley Fool owns shares of Bank of America and JPMorgan Chase.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.